(Q33702814)

28 July 2017

1 reference

title

Applications of oriP plasmids and their mode of replication (English)

1 reference

28 July 2017

Mackey D

1

1 reference

PubMed ID

10432462

28 July 2017

Sugden B

series ordinal

2

1 reference

PubMed ID

10432462

28 July 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

28 July 2017

Methods in Enzymology

1 reference

28 July 2017

306

1 reference

28 July 2017

308-328

1 reference

A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

The average number of molecules of Epstein-Barr nuclear antigen 1 per cell does not correlate with the average number of Epstein-Barr virus (EBV) DNA molecules per cell among different clones of EBV-immortalized cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

An EBV-based vector allowing a high level of LTRHIV-directed expression in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Improved expression cloning using reporter genes and Epstein-Barr virus ori-containing vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Transfer of cloned human class I major histocompatibility complex genes into HLA mutant human lymphoblastoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Expression and rescuing of a cloned human tumour necrosis factor gene using an EBV-based shuttle cosmid vector.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Rapid generation of stable cell lines expressing corticotropin-releasing hormone receptor for drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Utilization of an Epstein-Barr virus replicon as a eukaryotic expression vector

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Production of human tissue-type plasminogen activator in different mammalian cell lines using an Epstein-Barr virus vector

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Expression of recombinant calf prochymosin in mammalian cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Use of Epstein-Barr virus-based vectors for expression of thyroid auto-antigens in human B-lymphoblastoid cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Efficient synthesis of influenza virus hemagglutinin in mammalian cells with an extrachromosomal Epstein-Barr virus vector.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Expression of the hepatitis B virus surface antigen in mammalian cells using an Epstein-barr-virus-derived vector

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Episomal vectors rapidly and stably produce high-titer recombinant retrovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

The use of Epstein-Barr virus-based shuttle vectors in rat PC12 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

High frequency retrotransposition in cultured mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

An episomal vector for stable tetracycline-regulated gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Epstein-Barr virus episome-based promoter function in human myeloid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Comparative study of Epstein-Barr virus and SV40-based shuttle-expression vectors in human repair-deficient cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

A reporter system using a flow cytometer to detect promoter/enhancer activity in lymphoid cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Nucleosomal arrangement of HIV-1 DNA: maps generated from an integrated genome and an EBV-based episomal model

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Epstein-Barr virus shuttle vector for stable episomal replication of cDNA expression libraries in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Efficient cDNA cloning by direct phenotypic correction of a mutant human cell line (HPRT−) using an Epstein - Barr virus-derived cDNA expression vector

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Expression cloning of a human DNA repair gene involved in xeroderma pigmentosum group C

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Cloning muscle isoforms of neural cell adhesion molecule using an episomal shuttle vector

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Construction and properties of an Epstein-Barr-virus-derived cDNA expression vector for human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

High-frequency transformation of human repair-deficient cell lines by an Epstein-Barr virus-based cDNA expression vector

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Selective extraction of polyoma DNA from infected mouse cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Mutational specificities of 1'-acetoxysafrole, N-benzoyloxy-N-methyl-4-aminoazobenzene, and ethyl methanesulfonate in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Misincorporation rate and type on the leading and lagging strands of UV-damaged DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

A shuttle system for transfer of YACs between yeast and mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Stable episomal maintenance of yeast artificial chromosomes in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Improved EBV-based shuttle vector system: dicistronic mRNA couples the synthesis of the Epstein-Barr nuclear antigen-1 protein to neomycin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Mitotic stability of yeast chromosomes: a colony color assay that measures nondisjunction and chromosome loss

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Genetic analysis of the mitotic transmission of minichromosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

A genetic analysis of dicentric minichromosomes in Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Isolation of human sequences that replicate autonomously in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Replication initiates at multiple locations on an autonomously replicating plasmid in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

The domain of Epstein-Barr virus nuclear antigen 1 essential for binding to oriP region has a sequence fitted for the hypothetical basic-helix-loop-helix structure

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein EBNA 1

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein, EBNA1, bound to DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Crystal structure at 1.7 A of the bovine papillomavirus-1 E2 DNA-binding domain bound to its DNA target

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Activation of BPV-1 replication in vitro by the transcription factor E2.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Transactivation of a bovine papilloma virus transcriptional regulatory element by the E2 gene product

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Mutational analysis of Epstein-Barr virus nuclear antigen 1 (EBNA 1).

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

DNA binding activity is required for EBNA 1-dependent transcriptional activation and DNA replication

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

DNA helicase activity of SV40 large tumor antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Epstein-Barr virus nuclear antigen 1 forms a complex with the nuclear transporter karyopherin alpha2.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

The role of the nuclear pore complex in adenovirus DNA entry

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Molecular cloning of human fibroblast hyaluronic acid-binding protein confirms its identity with P-32, a protein co-purified with splicing factor SF2. Hyaluronic acid-binding protein as P-32 protein, co-purified with splicing factor SF2

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Identification of Epstein-Barr virus nuclear antigen 1 protein domains that direct interactions at a distance between DNA-bound proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Studies on the mechanism of DNA linking by Epstein-Barr virus nuclear antigen 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

DNA looping between sites for transcriptional activation: self-association of DNA-bound Sp1

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Direct interaction between Sp1 and the BPV enhancer E2 protein mediates synergistic activation of transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Subnuclear localization and phosphorylation of Epstein-Barr virus latent infection nuclear proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Formation of de novo centromeres and construction of first-generation human artificial microchromosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Plasmid-encoded hygromycin B resistance: the sequence of hygromycin B phosphotransferase gene and its expression in Escherichia coli and Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Plasmid maintenance of derivatives of oriP of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Regulation of EBNA gene transcription in lymphoblastoid cell lines: characterization of sequences downstream of BCR2 (Cp).

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Definition of the sequence requirements for binding of the EBNA-1 protein to its palindromic target sites in Epstein-Barr virus DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

EBNA1 can link the enhancer element to the initiator element of the Epstein-Barr virus plasmid origin of DNA replication

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Interaction of the lymphocyte-derived Epstein-Barr virus nuclear antigen EBNA-1 with its DNA-binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Dominant-negative inhibitors of EBNA-1 of Epstein-Barr virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Rep*: a viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Epstein-Barr virus nuclear antigen forms a complex that binds with high concentration dependence to a single DNA-binding site

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Purification and characterization of UL9, the herpes simplex virus type 1 origin-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Cellular protein modulates effects of human immunodeficiency virus type 1 Rev

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

Herpes simplex virus origin-binding protein (UL9) loops and distorts the viral replication origin

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906020-6

7 January 2021

10.1016/S0076-6879(99)06020-6

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10432462